These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 32429195)

  • 21. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities.
    Alzahrani J; Hussain T; Simar D; Palchaudhuri R; Abdel-Mohsen M; Crowe SM; Mbogo GW; Palmer CS
    EBioMedicine; 2019 Aug; 46():522-531. PubMed ID: 31327693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure.
    Nardone OM; de Sire R; Petito V; Testa A; Villani G; Scaldaferri F; Castiglione F
    Front Immunol; 2021; 12():694217. PubMed ID: 34326845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.
    Martin FP; Su MM; Xie GX; Guiraud SP; Kussmann M; Godin JP; Jia W; Nydegger A
    World J Gastroenterol; 2017 May; 23(20):3643-3654. PubMed ID: 28611517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
    Ijssennagger N; van der Meer R; van Mil SWC
    Trends Mol Med; 2016 Mar; 22(3):190-199. PubMed ID: 26852376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism at the centre of the host-microbe relationship.
    Maslowski KM
    Clin Exp Immunol; 2019 Aug; 197(2):193-204. PubMed ID: 31107965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.
    Cohen LJ; Cho JH; Gevers D; Chu H
    Gastroenterology; 2019 Jun; 156(8):2174-2189. PubMed ID: 30880022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease.
    Wu GD
    Nestle Nutr Inst Workshop Ser; 2016; 84():103-10. PubMed ID: 26764479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota and metabolic syndrome.
    Wang PX; Deng XR; Zhang CH; Yuan HJ
    Chin Med J (Engl); 2020 Apr; 133(7):808-816. PubMed ID: 32106124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site.
    Konjar Š; Pavšič M; Veldhoen M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach.
    Verma A; Sharda S; Rathi B; Somvanshi P; Pandey BD
    Sci Rep; 2020 Sep; 10(1):15131. PubMed ID: 32934294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.
    Sáez-González E; Mateos B; López-Muñoz P; Iborra M; Moret I; Nos P; Beltrán B
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration.
    Priya S; Burns MB; Ward T; Mars RAT; Adamowicz B; Lock EF; Kashyap PC; Knights D; Blekhman R
    Nat Microbiol; 2022 Jun; 7(6):780-795. PubMed ID: 35577971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The microbiota of intestine. The role in development of various pathologies].
    Kuznetsova EE; Gorokhova VG; Bogorodskaya SL
    Klin Lab Diagn; 2016 Oct; 61(10):723-6. PubMed ID: 30615347
    [No Abstract]   [Full Text] [Related]  

  • 40. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.